SuperworthSilexion Therapeutics shares outstanding SLXN
Diluted shares outstanding, averaged over each quarter, from 2023.
- Latest quarter, to Jun 30, 2026
- 687.4K
- On a year earlier
- +1086.1%
- more shares
Silexion Therapeutics had 687.4K diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 1086.1% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 687.4K | +1086% | |
| Q1 FY26 | 323K | +615% | |
| Q3 FY25 | 113.3K | +2521% | |
| Q2 FY25 | 58K | +7687% | |
| Q1 FY25 | 45.2K | +5968% | |
| Q3 FY24 | 4.3K | +480% | |
| Q2 FY24 | 744 | +298% | |
| Q1 FY24 | 745 | +298% | |
| Q3 FY23 | 745 | n/a | |
| Q2 FY23 | 187 | n/a | |
| Q1 FY23 | 187 | n/a |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Silexion Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.